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Nucleolus organizer region – NOR
Ribosomal DNA – rDNA
Ribosomal RNA – rRNAa b s t r a c t
Background: Intellectual disability (ID) is an important medical and social problem that can be caused by
different genetic and environmental factors. One such factor could be rDNA amplification and changes in
rRNA expression and maturation.
Aim of the study: The aim of the present study was to investigate rRNA levels in patients with heteromor-
phism of the p-arms of acrocentric chromosomes bearing nucleolus organizer regions compared to a
healthy control group.
Material and methods: Frequencies of p-arms enlargements in patients with ID and in healthy people were
analyzed by G-banding screening. rRNA gene copy numbers on affected acrocentric chromosomes in
peripheral blood lymphocytes were evaluated in ID patients and healthy bearers using FISH, and in
immortalized lymphocytes of one patient – using FISH and real time PCR. Simultaneously, levels of
18S, 28S and 5,8S rRNA in both groups by means of qRT-PCR were investigated.
Results: No difference in acrocentric chromosome heteromorphism frequency in patients versus the
healthy group were found. However, we found an amplification of rDNA, a significant elevation in 28S
and 5.8S rRNA expression and changes in the 28S/18S rRNA ratio in ID patients compared to healthy con-
trols. At the same time, FISH appeared to be not reliable enough for copy number evaluation, but RT-PCR
showed rDNA copy changes in heteromorphic cells compared to normal.
Conclusion: Our findings indicate a loss of the correct regulation of rDNA activity and processing after
amplification. This could disturb the ribosomal apparatus and thus lead to intellectual disability via at
least two mechanisms.
 2017 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
ID is an important medical and social problem that is commonly
accompanied with comorbidities, as well as psychological issues,
social difficulties and often financial pressure for patients and their
relatives. Its frequency is approximately 1% of the human popula-tion, and it can be caused by different genetic and/or environmen-
tal factors. To date, more than 700 genes related to ID have been
described. Many types of ID are associated with chromosome
abnormalities [1]. One genetic feature that could be related to ID
is enlargement of the p-arms on acrocentric chromosomes.
Although acrocentric chromosomes with NOR regions with sub-
stantially enlarged p-arms were reported since the 1970s, these
can be accompanied by ID or be present in healthy people [2–4]
and even pass through generations [5,6]. In these cases, substantial
amplification of rDNA was rarely shown because very few reports
investigated rDNA in enlarged p-arms of marker chromosomes.
Moreover, few cases have investigated NOR activity, and there
are no reports about rRNA levels measured quantitatively in bear-
ers of NOR-chromosomes with enlarged p-arms. In addition, it
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acrocentric chromosomes is considered normal by the human
chromosome atlas; moreover, these chromosomes are considered
the most variable in the human karyotype [7]. It is important to
note that changes and/or impairment in rRNA expression have
been reported in neurodegenerative diseases, such as Alzheimer’s
disease [8,9] and Huntington disease [10,11], and increased NOR
activity has been shown in lymphocytes and buccal epithelium of
children with Down syndrome [12,13]. We propose that ID corre-
lates with NOR activity and rRNA expression levels, and so rRNA
levels could play a substantial role in the development of ID. Thus,
the main aim of our present study was to examine rDNA amounts
and rRNA expression levels and acrocentric chromosomes with p-
arms enlargement in patients with ID and in healthy controls.2. Ethics
The involvement of patients, their relatives and random donors
in the study was strictly designed in accordance with international
standards, which include the awareness of the subject and his or
her informed consent to participate in the study in its entirety
and guarantees of confidentiality. All studies conformed to ethical
standards developed in accordance with the Helsinki Declaration
of the World Medical Association, as amended in 2000. In addition,
the studies were supervised by the Institutional Review Board.3. Materials and methods
3.1. Investigated groups
A total of 88 blood samples from the IMCB SB RAS repository
were studied. Fifty-six samples were from ID individuals and the
remaining 32 were from healthy controls.
For the molecular investigation, 12 patients with UID and with
heteromorphism of acrocentric chromosomes as determined by G-
banding and without other genetic abnormalities were selected.
Six of the 12 patients had diagnoses of mild intellectual disability,
and the remaining patients had other diagnoses related to ID
(hyperkinetic conduct disorder, infantile autism etc.). The average
age of this group was 7.1 ± 1.8 years. The control group included 13
healthy persons without any known genetic diseases. The average
age of this group was 27.4 ± 1.6 years. The differences in age
between groups arised, because patients involved in the present
study were children addressed to diagnostics due to ID, and
healthy donors were their parents/sibs or randomly selected peo-
ple. Healthy children had no need to be diagnosed and thus were
not present in the study.
3.2. Metaphase preparation and staining
Blood samples were cultivated in RPMI-1640 medium (Gibco,
USA) with 20% Fetal bovine serum (Gibco) and 1–3% PHA-M
(Gibco) for 72 h. Incubation with 0.03 lg/ml of KaryoMax colcemid
solution (Gibco) and 2.5 lg/ml ethidium bromide for 3 h was fol-
lowed by hypotonic treatment for 25 min and fixation in CarnoyTable 1
Primers used for evaluation of the rRNA levels and rDNA
Target Forward primer
18S rRNA 50-GAGAAACGGCTACCACATCCAA -30
28S rRNA 50-GGGTGGTAAACTCCATCTAAGG -30
5,8S rRNA 50-GGTGGATCACTCGGCTCGT -30
Beta-actin 50-CACGGCATCGTCACCAACTG -30
GAPDH 50-CTGCAGGGCCTCACTCCTTTTGCAG-3fixative (methanol/acetic acid – 3/1). Immortalized cell lines
GM06895 (Coriell Institute Cell Repository, USA) and CPG148
(IMCB SB RAS cell repository) were cultivated in RPMI-1640 med-
ium (Gibco) with 15% fetal bovine serum (Gibco) and 4 mM L-
glutamine (Gibco). Metaphases were prepared by dropping the cell
suspension. For G-banding [14], metaphases were treated with
0.25% trypsin solution for 1 min and staining with Giemsa stain
for 2 min. Slides were analyzed on an Olympus BX-53 microscope
with 1000 total magnification. For image capture and analysis,
VideoTest Karyo 3.1 (iMicroTec, Russia) software was used. For
each case, no less than 12 metaphase spreads were analyzed.3.3. Fluorescent in situ hybridization (FISH)
Plasmid pHr13 containing genes for 18S, 28S and 5.8S rRNA [15]
was labeled with a BioNick DNA labeling system (ThermoFisher
Scientific, USA). Before FISH, slides were pretreated with 100 lg/
ml RNAse for 1 h at 40 C and with 0.005% pepsin solution in
10 mM HCl for 10 min at 37 C (if not G-banded before). FISH
was performed with 0.06 ng of the labeled probe in 50% formamide
at 40 C overnight. Detection was performed with Alexa-555-
streptavidin conjugate (ThermoFisher Scientific) or using FITC-
conjugated avidin and anti-avidin antibody (both from New Eng-
land Biolabs, USA). Chromosomes were counterstained with DAPI
(0.08 lg/ml). Slides were analyzed on an Olympus BX-53 micro-
scope with 1000 total magnification. For image capture and anal-
ysis, VideoTest FISH 2.0 (iMicroTec, Russia) software was used.3.4. RNA isolation, cDNA producing and qRT-PCR
Total RNA extraction from whole blood or blood plasma was
performed using an Aurum Total RNA Mini Kit (BioRad, USA) or
ExtractRNA reagent (Eurogen, Russia) followed by reverse tran-
scription using an iScript Select cDNA Synthesis Kit (BioRad). All
procedures were performed according to the manufacturers’ proto-
cols. Real-Time PCR was performed using SsoAdvanced Universal
SYBR Green Supermix (BioRad) in a C1000 Touch Thermal Cycler
with a CFX 96 RealTime System (BioRad).
Primers for real-time PCR (Table 1) were designed using ref. seq
NR_003286.2, NR_003287.2 and NR_003285.2 for 18S, 28S and
5.8S rRNA, respectively. Beta-actin (ref.seq. NM_001101.3) was
used as a reference gene. A healthy male donor (CPG57 according
to IMCB SB RAS nomenclature) was used as a control for the rRNA
level evaluation in all cases. Each sample was measured in 3 anal-
yses [16].3.5. DNA isolation and RT-PCR
Genomic DNA from immortalized cell lines GM06895 and
CPG148 was extracted using a Wizard Genomic DNA purification
kit (Promega, USA) according to the manufacturer’s protocol.
Real-time PCR was performed using the same primers as for 18S,
28S and 5.8S rRNA expression level estimation (see section above),
but GAPDH was used as a single copy reference (ref.seq.







Fig. 2. Different types of rDNA signals on metaphase spreads with p-arm
enlargements in acrocentric chromosomes. a – Enlarged signal on an affected
chromosome (arrow) in a healthy control, b – Large signals on both affected and
normal chromosomes (arrows) in an ID patient, c –Equally sized signals on both
affected and normal chromosomes (arrow) in a healthy control. Left: FISH
localization of dig-labeled rDNA (red); right: same G-banded metaphase.
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estimated using MS Excel software (Microsoft, USA).
3.6. Statistics
Statistical comparison of obtained data between groups was
performed by Student’s t-test using GraphPad software (http://
www.graphpad.com/quickcalcs). We considered differences statis-
tically significant if p < 0.05.
4. Results
4.1. Analysis of acrocentric chromosome p-arm heteromorphism
In the IMCB SB RAS, we have a collection of blood samples of
patients with ID and their relatives. We performed G-banding
screening of the patients to identify karyotype features that could
be associated with ID. The NOR-chromosome p-arm was consid-
ered to be enlarged if it was comparable or longer than the p-
arm of chromosome 18 [7]. First, we performed statistical evalua-
tion of acrocentric chromosomes with NOR region p-arm enlarge-
ment of the 56 ID patients and the 32 healthy controls. In the ID
group, 21 patient (37.5 ± 5.9%) had enlarged p-arms in acrocentric
chromosomes. In the healthy group, p-arm heteromorphism was
revealed in 11 patients (34.4 ± 8.4%). Thus, the difference in the fre-
quency of acrocentric chromosomes with p-arm heteromorphism
between the groups was not statistically significant. This finding
shows that this feature itself is not directly connected with an
increased probability of ID development, although it can be
thought to represent a risk factor. Interestingly, chromosome 13
had more frequent p-arm enlargement compared to other chromo-
somes. We found 13p+ in 17 of 24 ID p+ cases (70.8 ± 9.3%) (Fig. 1,
a). Among healthy bearers of acrocentric chromosomes with
enlarged p-arms, 13p+ was also the most frequent, being observed
in 8 of 12 cases (66.7 ± 13.6%) (Fig. 1, b). Thus, chromosome 13
tends toward preferential p-arm enlargement among all analyzed
people with acrocentric chromosome heteromorphisms.
4.2. rRNA genes localization by FISH
Enlarged p-arms of acrocentric chromosomes contain rRNA
genes (rDNA). To investigate if enlargement leads to rDNA amplifi-
cation, we hybridized a plasmid, pHr13, which contains genes ofFig. 1. Distributions of heteromorphism in acrocentric chr18S, 28S and 5.8S rRNA, to metaphase spreads of 12 ID patients
with heteromorphic acrocentric chromosomes and 9 healthy con-
trols with heteromorphic acrocentric chromosomes. There was
substantial heterogeneity in signal size and shape within individ-
ual metaphase spreads of patients and of healthy controls.
Although we observed signal enlargements on acrocentric chromo-
somes with enlarged p-arms (Fig. 2a), we often observed large sig-
nals on p-arms of acrocentric chromosomes that did not meet theomosomes in ID patients (a) and healthy controls (b).
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cases, the FISH signal on affected chromosomes was small and
did not differ from homologs and normal acrocentric chromosomes
(Fig. 2c). We did not observe any substantial difference in signal
distribution between ID patients and healthy bearers of acrocentric
chromosomes with enlarged p-arms. rRNA gene repetitive unit
copy number is known to vary widely, not only between individu-
als but also between cells within one individual. Additionally, FISH
signal size difference can result from hybridization efficiency on
individual chromosomes. FISH analysis does not allow for an esti-
mation of rDNA amplification.
4.3. Quantitative evaluation of rRNA genes in patient’s DNA
Blood samples held in the IMCB SB RAS repository were col-
lected in heparinized vacuum tubes to facilitate lymphocyte cul-
tures. Heparin is known to inhibit PCR, making rDNA
quantification by RT-PCR on collected samples unreliable. To study
possible rDNA amplification we purified DNA from cell cultures of
a patient with ID and heteromorphic chromosomes 13 and 15
(CPG148 according to IMCB SB RAS nomenclature). FISH analysis
(Fig. 3) of this patient showed larger and brighter rDNA signals
on both chromosomes with enlarged p-arms and a bright and large
signal on chromosome 22. We estimated the rDNA copy number in
these cells by real-time PCR relative to a control cell line,
GM06895. Copy numbers of sequences corresponding to 18S and
5.8S rRNA in CPG148 are 19.60 ± 0.82 and 20.09 ± 0.13 times the
level of these genes in GM06865, respectively, and for the 28S
sequence it is 9.60 ± 0.15 times the level in GM06865.
4.4. rRNA gene expression
Finally, we examined 18S, 28S and 5.8S rRNA levels in blood
samples of 12 ID patients with enlarged p-arms of acrocentric
chromosomes and 13 healthy controls. The control group included
samples with and without acrocentric chromosome heteromor-
phism. One healthy reference control with a normal karyotype
was used for normalization in all cases. The ID patient group was
heterogenic by rRNA gene expression levels in contrast to the con-
trol group. Nevertheless, the mean 28S rRNA and 5.8S rRNA levels
were substantially and statistically significantly higher in ID
patients (p  0.01) compared with the control group, being 6.1
and 6.4-fold elevated, respectively, when normalized to a reference
control (Fig. 4). The 18S rRNA did not exhibit a statistically signif-Fig. 3. Localization of dig-labeled rDNA (red) on chromosomes of patient CPG148. Arr
G-banded metaphase.icant difference between ID patients and healthy controls,
although the value for ID patients tended to be higher (p = 0,12).
All healthy controls showed no statistical significance in rRNA
levels in relation to the presence of heteromorphic acrocentric
chromosomes.5. Discussion
A comparison of different population studies presented in the
Atlas of human acrocentric chromosome heteromorphisms [7]
shows some discrepancies due to racial and population (e.g. age
distributions) differences, as well as variations in staining tech-
niques and criteria used in the analyses. Moreover, all of these
studies were performed before 1980. However, preferential hetero-
morphism segregation for chromosome 13, which was found in
both ID patients and controls in our study, has been reported pre-
viously for other populations [17–19]. The most important finding
in our study is an absence of a difference in acrocentric chromo-
some p-arm heteromorphism frequencies between ID patients
and healthy controls. This indicates that acrocentric chromosome
p-arm heteromorphism is not the main and direct cause of ID.
Traditionally, rRNA gene number in humans has been estimated
to be approximately 300 copies per diploid human genome, vary-
ing from 100 to 400–600 (thus, 4–6-fold) between individuals
[20,21]. However, the latest data from ribosomal repeat sequenc-
ing in the human genome shows a very high polymorphism in
rDNA dosage, varying from 6.15 times for 18S to 10.85 times for
28S and to 46.78 times for 5.8S differences in the normal human
diploid genome. Moreover, although the precursor 45S transcript
arises from one single copy unit, meaning that the amount of all
3 corresponding rRNA sequences should be equal, at least approx-
imately when considering methodological and computational
errors, there can be differences between 18S, 28S and 5.8S
sequence numbers in a single genome [22]. Thus, recombination
in rDNA repeat areas is more difficult to determine than it should
seem. In our research in CPG148, we found approximately equal
amounts of 18S and 5.8S sequences but a different amount of
28S sequences. The amount of 18S corresponding sequences in
CPG148 (which had bright and large FISH-signals on affected chro-
mosomes) relative to GM06895 exceeded the normal variation,
while 28S corresponding sequences were within the normal varia-
tion, and 5.8S did not differ. Thus, it could be supposed that the p-
arm enlargement of chromosomes 13 and 15, at least in CPG148, is
accompanied by changes in the rRNA genes and the correspondingows indicate chromosomes with enlarged p-arms. Left: FISH results; right: same
Fig. 4. rRNA levels in studied samples.
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CPG148 are consistent with the FISH results. Considering the data
obtained in this study, it can be concluded that p-arm enlargement
of acrocentric chromosomes with NOR regions is accompanied by
rDNA over amplification, at least in some cases.
Correct ribosome assembly was shown to be essential for nor-
mal neural (dendritic tree) development [23], and perturbation of
rRNA synthesis was shown to lead to neurodegeneration in mice
[24]. Thus, rRNA level could play a substantial role in the develop-
ment of ID. The obtained results support our proposed relationship
between RNA levels and ID. Although we did not observe signifi-
cant differences in 18S rRNA levels between patients and controls
(although the mean 18S rRNA level in the group of patients tended
to be higher), significantly elevated 28S and 5.8S rRNA levels were
found in ID patients.
These results show that heteromorphism itself may not be the
main cause of ID, although it may be thought to be a risk factor.
We want to emphasize that the frequencies of p-arm enlargements
in acrocentric chromosomes with NOR regions do not significantly
differ between ID patients and controls; however, rRNA levels in
patients are higher compared not only to healthy controls with
normal karyotypes but also – and this is most important – to
healthy people with enlarged p-arms of acrocentric chromosomes
with NOR regions. Thus, excessive copies of rDNA repetitive units
appear to not be crucial themselves. It was shown in chicken cell
lines with excessive rDNA (tri- or tetrasomic for the NOR-bearing
chromosomes) that rRNA expression levels did not differ from that
of fully normal diploid cells [25,26]. Therefore, one of the possible
mechanisms of ID development seems to be rDNA hyperactivity
due to unrevealed causes, which could include disturbance of its
regulation. Activity of rRNA genes is regulated by the very large
amount of factors, and altered activity of any of them (i.e. due to
mutation) could cause loss of dosage compensation, and the search
of these factors is one of the next directions of our work.
However, elevated NOR activity is not the only factor playing a
role. The 28S/18S rRNA ratio in ID patients also tends to be
increased compared to healthy controls, but this is evidently the
case only for a subset of the patients. Thus, changes in rRNA mat-
uration processes may also be connected with ID development.Payao et al., upon observing a changed 28S/18S rRNA ratio in Alz-
heimer patients, proposed preferential degradation of 28S rRNA or,
in some patients, all major rRNA subunits [8]. In ID patients with
heteromorphism of acrocentric chromosomes with NOR regions,
we also observed this ratio shift, but in the opposite direction.
We did not observe an increased 28S/18S ratio in any patient. Thus,
preferential 28S rRNA degradation and decreased rRNA levels may
be a feature of neurodegeneration but not congenital ID develop-
ment. In contrast, ID may be caused or accompanied by excessive
activity of rDNA and, additionally, by 18S rRNA degradation (due
to unknown causes and mechanisms that still have to be revealed)
after splicing of the 45S primary transcript, and this might be asso-
ciated with rDNA hyperactivity in some patients. In both cases,
however, pathological changes in rRNA expression and/or matura-
tion occur.6. Conclusion
Our results show that acrocentric chromosome p-arm enlarge-
ments and excessive rDNA in them are not sufficient to cause ID.
The crucial control point is rRNA expression and, namely, its cor-
rect regulation and dosage compensation. If amplified rDNA
becomes hyperactive and/or processing is disturbed, problems
can arise. Thus, at least two mechanisms may occur, by which
development of ID in people with acrocentric chromosome hetero-
morphism is possible. Disturbance of ribosomal apparatus occurs,
which could impair neural system development and crucial
changes leading to ID. However, the triggers of these pathologic
processes wait to be revealed.Conflict of interests
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